uniQure Gets Back Gene Therapy After Chiesi Ends Partnership

uniQure will regain the rights for their hemophilia B gene therapy as the Chiesi Group backs out from working partnership...

uniQure Reacquires Rights for Gene Therapy Candidate

uniQure N.V. entered an agreement with Chiesi Group to reacquire the rights to co-develop and commercialize its hemophilia B gene...